Back
Adaptive Biotechnologies Stock Price Chart

Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73
ADPT
Adaptive Biotechnologies
Last Price:
$9.29
Seasonality Move:
19.88%
7 Day Trial
ALL ACCESS PASS
$
7

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADPT is experiencing slight buying pressure.
Adaptive Biotechnologies Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.08 | Buy |
20-day SMA: | 8.14 | Buy |
50-day SMA: | 7.94 | Buy |
200-day SMA: | 6.26 | Buy |
8-day EMA: | 8.97 | Buy |
20-day EMA: | 8.45 | Buy |
50-day EMA: | 8.02 | Buy |
200-day EMA: | 6.64 | Buy |
Adaptive Biotechnologies Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.42 | Buy |
Relative Strength Index (14 RSI): | 61.36 | Buy |
Chaikin Money Flow: | 250941 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.23 - 8.95) | Buy |
Bollinger Bands (100): | (6.77 - 8.43) | Buy |
Adaptive Biotechnologies Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Adaptive Biotechnologies Stock
Is Adaptive Biotechnologies Stock a Buy?
-
Adaptive Biotechnologies share price is 9.51 while ADPT 8-day simple moving average is 9.08, which is a Buy signal.
-
The stock price of ADPT is 9.51 while Adaptive Biotechnologies 20-day SMA is 8.14, which makes it a Buy.
-
Adaptive Biotechnologies 50-day simple moving average is 7.94 while ADPT share price is 9.51, making it a Buy technically.
-
ADPT stock price is 9.51 and Adaptive Biotechnologies 200-day simple moving average is 6.26, creating a Buy signal.
ADPT Technical Analysis vs Fundamental Analysis
Buy
73
Adaptive Biotechnologies (ADPT)
is a Buy
Is Adaptive Biotechnologies a Buy or a Sell?
-
Adaptive Biotechnologies stock is rated a BuyThe current Adaptive Biotechnologies [ADPT] share price is $9.51. The Score for ADPT is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Adaptive Biotechnologies Stock Info
Market Cap:
1.4B
Price in USD:
9.51
Share Volume:
1.6M
Adaptive Biotechnologies 52-Week Range
52-Week High:
10.28
52-Week Low:
2.99
Buy
73
Adaptive Biotechnologies (ADPT)
is a Buy
Adaptive Biotechnologies Share Price Forecast
-
What is the Adaptive Biotechnologies stock price today?The Adaptive Biotechnologies stock price is 9.51 USD today.
-
Will ADPT stock go up or go down?Adaptive Biotechnologies> share price is forecast to RISE/FALL based on technical indicators
-
Is Adaptive Biotechnologies overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptive Biotechnologies is not overvalued.
Is Adaptive Biotechnologies Stock a Buy?
-
Adaptive Biotechnologies share price is 9.51 while ADPT 8-day exponential moving average is 8.97, which is a Buy signal.
-
The stock price of ADPT is 9.51 while Adaptive Biotechnologies 20-day EMA is 8.45, which makes it a Buy.
-
Adaptive Biotechnologies 50-day exponential moving average is 8.02 while ADPT share price is 9.51, making it a Buy technically.
-
ADPT stock price is 9.51 and Adaptive Biotechnologies 200-day simple moving average is 6.64, creating a Buy signal.
Fundamental Analysis of Adaptive Biotechnologies
Is Adaptive Biotechnologies a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.27 per share, and an increase next year of $0.23 per share.
Technical Analysis of Adaptive Biotechnologies
Should I short Adaptive Biotechnologies stock?
-
ADPT Moving Average Covergence Divergence (MACD) indicator is 0.42, suggesting Adaptive Biotechnologies is a Buy
-
Adaptive Biotechnologies Relative Strength Index (RSI) is 61.36, which suggest Adaptive Biotechnologies is overbought
-
The Bollinger Bands (25) for Adaptive Biotechnologies is (7.23 - 8.95), which suggest Adaptive Biotechnologies is a Buy
-
The Bollinger Bands (100) for Adaptive Biotechnologies is (6.77 - 8.43), which suggest Adaptive Biotechnologies is a Buy
* Adaptive Biotechnologies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.